Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study

Detalles Bibliográficos
Autores principales: Batista, José Gomes, Soares, José Maria, Maganhin, Carla Cristina, Simões, Ricardo Santos, Tomaz, Geraldez, Baracat, Edmund Chada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297040/
https://www.ncbi.nlm.nih.gov/pubmed/22473412
http://dx.doi.org/10.6061/clinics/2012(03)14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297040/
https://www.ncbi.nlm.nih.gov/pubmed/22473412
http://dx.doi.org/10.6061/clinics/2012(03)14

Ejemplares similares